Method of treatment of diabetic nephropathy by means of sulodexide of medicines containing it
US5496807A · kind A · utility
5Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 1994 |
| Grant date | Mar 5, 1996 |
| Priority date | — |
| Expiry date | Apr 14, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of sulodexide, a glycosaminoglycan of natural origin extracted from mammalian intestinal mucosa, and of medicines containing it in the treatment of patients suffering from nephropathy of diabetic origin constitutes the object of the present invention. The effectiveness of sulodexide has been shown by the significative decrease of the albuminuria in microalbuminuric and macroalbuminuric diabetic patients treated with pharmaceutical compositions administered by oral or intramuscular route containing therapeutically effective amounts of drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.